ProfileOfResearchers

TITLE: Can be MMP-7-153C/T a possible marker for distant metastasis risk in non small cell lung cancer? Full Text
AUTHORS: Gomes, M; Coelho, AL; Araujo, A ; Teixeira, AL; Medeiros, R;
PUBLISHED: 2015, SOURCE: European Cancer Congress in EUROPEAN JOURNAL OF CANCER, VOLUME: 51

INDEXED IN:

WOS

IN MY:

ORCID |

TITLE: Combined Ang-2 and VEGF serum levels: holding hands as a new integral biomarker in non-small-cell lung cancers
AUTHORS: Ana Luisa Coelho; Antonio Manuel Araujo ; Monica Patricia Gomes; Raquel Jorge Catarino; Elva Bonifacio Andrade ; Agostinho Marques Lopes; Rui Medeiros ;
PUBLISHED: 2015, SOURCE: FUTURE ONCOLOGY, VOLUME: 11, ISSUE: 24

INDEXED IN:

Scopus

WOS

IN MY:

ORCID |

TITLE: Comparative efficacy of ceritinib and crizotinib in previously treated crizotinib-naive anaplastic lymphoma kinase-positive (ALK plus ) advanced or metastatic non-small cell lung cancer (NSCLC): An adjusted indirect comparison.
AUTHORS: Daniel Shao Weng Tan; Antonio Araujo ; Jie Zhang; James E Signorovitch; Zheng Yi Zhou; Xiaopeng P Cai; Geoffrey Liu;
PUBLISHED: 2015, SOURCE: Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) in JOURNAL OF CLINICAL ONCOLOGY, VOLUME: 33, ISSUE: 15

INDEXED IN:

WOS

IN MY:

ORCID |

TITLE: IL-6 polymorphism in non-small cell lung cancer: a prognostic value?
AUTHORS: Gomes, M; Coelho, A; Araujo, A ; Azevedo, A ; Teixeira, AL; Catarino, R; Rui Medeiros ;
PUBLISHED: 2015, SOURCE: TUMOR BIOLOGY, VOLUME: 36, ISSUE: 5

INDEXED IN:

Scopus

WOS

Handle

IN MY:

ORCID |

TITLE: Circulating Ang-2 Mrna Expression Levels: Looking ahead to a New Prognostic Factor for NSCLC Full Text
AUTHORS: Coelho, AL; Araujo, A ; Gomes, M; Catarino, R; Marques, A; Rui Medeiros ;
PUBLISHED: 2014, SOURCE: PLOS ONE, VOLUME: 9, ISSUE: 2

INDEXED IN:

Scopus

WOS

IN MY:

ORCID |

TITLE: The Role of Inflammation in Lung Cancer
AUTHORS: Gomes, M; Teixeira, AL; Coelho, A; Araujo, A ; Rui Medeiros ;
PUBLISHED: 2014, SOURCE: INFLAMMATION AND CANCER, VOLUME: 816

INDEXED IN:

Scopus

WOS

IN MY:

ORCID |